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In the post-genomic era, various computational methods that predict protein-
protein interactions at the genome level are available; however, each method has its
own advantages and disadvantages, resulting in false predictions. Here we devel-
oped a unique integrated approach to identify interacting partner(s) of Semaphorin
5A (SEMA5A), beginning with seven proteins sharing similar ligand interacting
residues as putative binding partners. The methods include Dwyer and Root-
Bernstein/Dillon theories of protein evolution, hydropathic complementarity of
protein structure, pattern of protein functions among molecules, information on
domain-domain interactions, co-expression of genes and protein evolution. Among
the set of seven proteins selected as putative SEMA5A interacting partners, we
found the functions of Plexin B3 and Neuropilin-2 to be associated with SEMA5A.
We modeled the semaphorin domain structure of Plexin B3 and found that it
shares similarity with SEMA5A. Moreover, a virtual expression database search
and RT-PCR analysis showed co-expression of SEMA5A and Plexin B3 and these
proteins were found to have co-evolved. In addition, we confirmed the interac-
tion of SEMA5A with Plexin B3 in co-immunoprecipitation studies. Overall, these
studies demonstrate that an integrated method of prediction can be used at the
genome level for discovering many unknown protein binding partners with known
ligand binding domains.
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Introduction
Protein-protein interactions play a major role dur-
ing normal cellular functions or pathological diseases.
These protein-protein interactions are physically me-
diated by 4–7 amino acid residues (ligand binding re-
gions or binding signatures) at the interface of the
binding domain, while the other residues are involved
in bringing ligand binding residues structurally close
(1–9 ). Binding signatures of interacting proteins
can be identified from their known structural profile
(10 , 11 ) or using phage-display peptide library selec-
tion (1 , 12 , 13 ). Since the structure of most of the
proteins is unknown, identifying binding signatures
using a structural profile is not easy. However, us-
ing in vivo phage-display peptide library screening,
random seven amino acid peptides, expressed as part
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of a coat protein gene on the surface of bacterio-
phages, can be affinity selected against the receptor
on the membrane surface of organ-specific endothelial
cells by intravenous injection of the phages into mice.
These affinity selected peptides are the binding sig-
natures of proteins that interact with the receptor(s)
on endothelial cells (1 ). Therefore, we can predict the
protein-protein interactions underlying these binding
signatures or peptides.
Recently, we identified Semaphorin 5A
(SEMA5A) as a metastasis-associated protein by
bioinformatics analysis using binding signatures from
phage-display assay and in vivo selection (1 ). In order
to understand the biological significance of SEMA5A
expression, it is essential to identify its binding part-
ners or receptor. There are various methods available
that are being applied individually to predict protein-
protein interactions at the genome level, showing
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their relevance to predictions (14–16 ). However, each
method has its own disadvantages leading to incorrect
predictions. Among the experimental procedures, it
is already known that the yeast two-hybrid system
gives a significant number of false positives, while
mass spectrometry is expensive and time consuming
(17 , 18 ). On the other hand, computational methods
have their own disadvantages when used alone and
only a few methods provide a platform for biologists
to predict single protein-protein interactions. In this
study, we applied computational methods to predict
the interacting partners of SEMA5A using ligand
binding signatures screened from an in vivo phage-
display peptide library assay from our previous report
(1 ).
To our knowledge, for the first time we have ap-
plied ligand binding peptides combined with other
protein interaction prediction methods to identify
binding partners of SEMA5A. Our approach involved
prediction of SEMA5A binding partners from a set
of proteins sharing the binding signature, NAFT-
PDY, identified using phage-display screening com-
bined with bioinformatics analysis (1 ). The proce-
dure utilizes integration of various useful method-
ologies of protein-protein interactions already eluci-
dated (14–16, 19 , 20 ). Currently, we have used six
different theoretical methods for predicting the inter-
acting partners of SEMA5A. At each step, proteins
that fail to satisfy the criteria were dropped. This
integrative approach for the prediction of protein-
protein interactions can be expanded to identify bind-
ing partners for more proteins whose binding signa-
tures are already known.
Results
Peptide complementarity predicts pro-
tein interactions
Root-Bernstein and Dillon (RBD) theory suggests
that protein receptors will contain ligand-like se-
quences within the binding (extracellular) region, if
the peptide is self-complementary (21 ). A well-known
example is glucagon and glucagon receptor sharing
80% similar residues in their ligand binding regions.
Similarly, insulin and insulin receptor and gastrin-
gastrin binding protein interactions have also been
shown (21 ). The ligand binding sites of proteins can
be identified by phage-display peptide library screen-
ing (1 ). In our previous publication, we predicted
Plexin B3, Neuropilin-2 (NRP2), Integrin alpha-X
and -E, NETO1, Desmocolin 2 and Ephrin B2 along
with SEMA5A to contain NAFTPDY ligand binding
peptide in their extracellular binding regions through
a combination of phage-display peptide library and in
silico analyses (1 ). Since these proteins are predicted
to share the same putative ligand binding peptide and
the Semaphorin family of proteins is known to un-
dergo homophilic inteaction (self-aggregation), we se-
lected these proteins to identify the binding partner of
SEMA5A based on RBD theory of protein evolution.
For instance, it is interesting to note that the ligand
binding regions of both SEMA5A and Plexin B3 are
found in the semaphorin (sema) domain of the pro-
teins. It is already known that semaphorins and plex-
ins interact with each other through the sema domain
(22–25 ). This suggests that any of the seven proteins
may interact with SEMA5A at their putative ligand
binding regions. Hence, these proteins served as a
pool of proteins for further study to identify SEMA5A
interacting partners.
Functional association of proteins with
SEMA5A
Proteins associated with the same functions and
biological processes may interact with each other
(26 ). We tried to identify potential relationships of
SEMA5A with proteins sharing the putative bind-
ing signature, NAFTPDY, as a function of their co-
occurrence in the Gene Ontology (GO) database.
Therefore, we searched the functions of the proteins
associated with GO terms for semaphorins using the
GO database and Medline. The pattern of functional
co-occurrence was generated as described in the Meth-
ods section. The most significant biological processes,
cellular components and molecular functions for the
co-occurrence of these proteins are shown in Figure
1. From the GO database, we have selected twelve
terms associated with the Semaphorin family of pro-
teins. Among these terms, seven are from biological
processes, three are from cellular components and two
are from molecular functions. This is a representa-
tional analysis of GO terms for each protein for their
known functions and biological processes associated
with SEMA5A. This way of identifying relationships
is critical to predict the shared functions of these pro-
teins with SEMA5A. The frequency of co-occurrence
of the other proteins and their association rules in
relation to semaphorins were calculated. As per the
association rule, the minimum confidence at which
164 Geno. Prot. Bioinfo. Vol. 6 No. 3–4 2008
Sadanandam et al.
Fig. 1 Similar pattern of protein functions with SEMA5A. Functional association of proteins with SEMA5A was
modeled using GO terms associated with SEMA5A. If a protein shares the GO terms with SEMA5A, it is scored as 1
or else 0. The proteins are clustered using hierarchical clustering based on the score.
Table 1 Prediction of functional association between SEMA5A and listed proteins using functional
terms from GO database*
Proteins (X) Freq(Sema U X) Freq(X) Conf(Sema→X) Conf(X→Sema) Min. Confidence
Plexin B3 91.67 91.67 91.67 100 91.67
NRP2 91.67 91.67 91.67 100 91.67
Ephrin B2 58.33 58.33 58.33 100 58.33
NETO1 58.33 58.33 58.33 100 58.33
DSC2 25 25 25 100 25
ITGAE 16.67 16.67 16.67 100 16.67
ITGAX 16.67 16.67 16.67 100 16.67
*All the values represented are in percent. Freq(Sema U X) is the frequency of co-occurrence of all the functional
terms between SEMA5A and given proteins (X). Conf(Sema→X) or Conf(X→Sema) represents the confidence of the
functional association between SEMA5A and other proteins or vice versa. “Min. Confidence” is the minimal confidence
valued between Conf(Sema→X) and Conf(X→Sema). NRP2, neuropilin-2; NETO1, neuropilin and tolloid-like 1; DSC2,
desmocolin 2; ITGAE, integrin alpha-E, ITGAX, integrin alpha-X.
Plexin B3 and NRP2 co-occur with semaphorins is
91.67% (Table 1), respectively, whereas other pro-
teins occur at a confidence lower than the 75% ar-
bitrary cut-off. Similarly, modeling of known inter-
acting partners SEMA3C and NRP2 identified us-
ing the NAFTPDY peptide can be validated from
this functional association. Furthermore, the hier-
archical clustering shows that except for Plexin B3
and NRP2, all the other proteins are clustered away
from SEMA5A. These results suggest that Plexin B3
and NRP2 may be interacting partners for SEMA5A.
Therefore, Plexin B3 and NRP2 were considered for
further analyses.
Association of protein function based on
literature
Proteins cited in the same literature or text may be
involved in the same function. One suitable technique
for screening protein-protein interactions is text min-
ing (26 ). We constructed a similarity score using a co-
sine similarity measure that quantitatively measures
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the co-occurrences of selected proteins with SEMA5A
in searches using Google Scholar and PubMed. It
gives an index calculated between normalized vector
pairs (SEMA5A and selected proteins), which implies
whether or not similarity exists between SEMA5A
and a given protein but not the magnitude of the sim-
ilarity. However, the magnitude of interaction has al-
ready been demonstrated using hierarchical clustering
as shown in Figure 1. Even though cosine similarity
could be used for protein interaction studies, it be-
comes difficult to fit the measure to suit proteins con-
taining few citations. Therefore, we have eliminated
proteins having less than 500 hits from Google Scholar
or PubMed and are clustered away from SEMA5A.
The results show that Plexin B3 and NRP2 have co-
sine similarity of 0.98, which is close to 1. The closer
the cosine similarity measure to 1, the more often the
proteins coexist in the literature. This in turn sug-
gests that Plexin B3 and NRP2 may interact with
SEMA5A.
Hydropathic profile predicts SEMA5A
interacting proteins
According to molecular recognition theory, the ligand
binding residues of two interacting proteins may have
complementary hydropathic profiles (27 , 28 ). We
compared the hydropathic profile of SEMA5A with
Plexin B3 and NRP2 as shown in Figure 2. The re-
sults demonstrate that the putative ligand binding re-
gions of Plexin B3 and NRP2 have complementary
hydropathic indices compared to that of SEMA5A as
shown in the thicker lines (Figure 2). This further
predicts the interaction of SEMA5A with Plexin B3
and NRP2.
SEMA5A binding partners are co-
expressed in tissues
Interacting proteins are co-expressed in many tis-
sues (29 ). Therefore, we tested the expression of
SEMA5A, Plexin B3 and NRP2 using Gene Expres-
sion Atlas, UniGene expression profile and reverse
transcription polymerase chain reaction (RT-PCR).
Gene Expression Atlas showed that SEMA5A, Plexin
B3 and NRP2 are co-expressed in spinal cord, brain
and prostate tumors (data not shown). The Uni-
Gene expression profile shown in Figure 3A demon-
strates the co-expression of SEMA5A, Plexin B3 and
NRP2 in different tissues (brain, lung and spleen)
and embryonic stages (late gestational and neona-
tal mice). As a control, NETO1 was tested and
was not co-expressed in any of the SEMA5A ex-
pressing tissues except brain tissue (Figure 3A). Sim-
ilarly, RT-PCR using pancreatic cancer cell lines
shows that SEMA5A, Plexin B3 and NRP2 are co-
expressed in pancreatic cancer cell lines established
from metastases (Figure 3B). The RT-PCR data sug-
gest that SEMA5A interaction with Plexin B3 and
NRP2 may be involved in pancreatic tumor progres-
sion and metastasis. Overall, these results suggest
that SEMA5A may interact with Plexin B3 or NRP2.
Fig. 2 Hydropathic complementarity of proteins with SEMA5A. Kyte and Doolittle hydropathic profiles of SEMA5A,
Plexin B3 and NRP2 were calculated using ProtScale. The hydropathic scores were plotted using Microsoft ExcelTM.
Thick regions in the graph represent the regions corresponding to NAFTPDY residues in each protein. The binding
peptide corresponding to Plexin B3 and NRP2 have negative hydropathic index (complementary hydropathic values)
compared with that of SEMA5A.
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Fig. 3 Co-expression of SEMA5A with its putative binding partners. A. UniGene expression data for SEMA5A,
Plexin B3, NRP2 and NETO1 in different adult and fetal tissues. Except NETO1, the other genes are co-expressed
with SEMA5A. TPM, tags per million. B. RT-PCR analysis showing the co-expression of Plexin B3 and NRP2 with
SEMA5A in pancreatic cancer cell lines established from metastasis. Note that there is no expression of SEMA5A in
cell lines established from primary tumor.
Modeling of Plexin B3 structure
Homology modeling using the remote protein struc-
ture prediction server CPHmodels was performed to
design the structure of the sema domain of Plexin
B3, which has been predicted using the sema domain
of Met receptor. The structure of the sema domain
of Met receptor and Plexin B3 is shown in Figure
4A and their overlapping structure is shown in Figure
4B. Furthermore, Figure 4C shows that the predicted
ligand binding region from NAFTPDY peptide has
structural similarity to Met receptor.
Presence of similar domains infers pro-
tein interactions
As a derivation of the Rosetta Stone model, proteins
with similar domains may interact with each other
(26 ). PSI-BLAST and CDD search results showed
that Plexin B3 and SEMA5A have similar domains.
We have already predicted the structure of SEMA5A
in our previous publication (1 ). Here we compared
the structure of the sema domain of SEMA5A and
Plexin B3. The extracellular domains of Plexin B3
and SEMA5A shown in Figure 5A demonstrate that
they share the sema domain and PSI domain. Fur-
thermore, the structure of the sema domain of both
SEMA5A and Plexin B3 are similar as shown in Fig-
ure 5B. This suggests that SEMA5A and Plexin B3
may interact with each other through the sema do-
main.
SEMA5A and Plexin B3 co-evolved
Proteins clustered together phylogenetically tend to
function together and hence, interact with each other
(30 , 31 ). To test this, we generated a phylogenetic
tree using semaphorins and plexins. The result in Fig-
ure 6 shows a close evolutionary relationship between
SEMA5A and Plexin B3 together with less distance
within the Plexin family of proteins. This predicts
that SEMA5A and Plexin B3 may have co-evolved as
binding partners.
SEMA5A interacts with Plexin B3
Next, we confirmed the interaction of SEMA5A
with Plexin B3 in normal tissues co-expressing
SEMA5A and Plexin B3. We performed co-
immunoprecipitation using anti-PlexinB3 antibody
followed by immunobloting using anti-SEMA5A an-
tibody. Normal brain, lung and liver tissues from
rats were used. Results shown in Figure 7 demon-
strate that SEMA5A and Plexin B3 interact with each
other as they co-immunoprecipitated in brain, lung
and liver lysates.
Discussion
Recently, our laboratory has implicated the expres-
sion of SEMA5A in metastatic pancreatic cancer cell
lines but not in primary cancer cell lines (1 ). In ad-
dition, the report that mice knockouted for SEMA5A
died due to defects in the cranial vascular system (32 )
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Fig. 4 Molecular modeling of Plexin B3 protein. A. Molecular modeling of the sema domain of Plexin B3 was
performed using the web-based homology modeling server CPHmodels 2.0 utilizing Met receptor as a template. All
modeling was carried out using Swiss Model and was viewed using Swiss-PdbViewer. Note the structure of the sema
domain of Met (a) and Plexin B3 (b). B. The structure of the sema domain from Plexin B3 overlapped with that of
Met receptor. C. The amino acids corresponding to the binding peptide NAFTPDY are conserved and surface exposed
in Plexin B3 similar to Met receptor.
Fig. 5 Comparison of domains between SEMA5A and Plexin B3. A. Different domains in the extracellular regions
of SEMA5A and Plexin B3. Sema, semaphorin domain; PSI, photosystem I; TSP-1, thrombospondin specific repeats;
TIG/IPT, immunoglobulin-like fold shared by plexin and transcription factors. B. Structure of the sema domain of
SEMA5A (a), Plexin B3 (b) and their overlapping image (c).
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Fig. 6 Co-evolution of SEMA5A with Plexin B3. Phylogenetic tree with distance is shown for Semaphorin and Plexin
families of proteins. The phylogenetic tree shows a close evolutionary relationship between SEMA5A and Plexin B3,
representing the co-evolution of the two proteins.
Fig. 7 Co-immunoprecipitation of SEMA5A and PlexinB3. Tissue lysates were immunoprecipitated using anti-
PlexinB3 and IgG control antibodies and were then immunoblotted using anti-SEMA5A antibody.
demonstrates the importance of SEMA5A in the de-
velopment of the vascular system in embryos. These
studies show the significance of SEMA5A in cancer
and developmental biology, suggesting the importance
of identifying SEMA5A interacting proteins. Iden-
tification of a SEMA5A binding partner would add
great value to its functional study. In this report, we
have shown Plexin B3 as a primary binding partner
for SEMA5A using a novel sequence of computational
protein interaction prediction method. We are illus-
trating for the first time the application of peptide
and hydropathic complementarity along with a unique
sequence of methods to predict protein-protein inter-
actions. We have also modeled the 3D structure of
the sema domain of Plexin B3 and identified the pu-
tative ligand binding peptide that may regulate the
binding of SEMA5A with Plexin B3. However, this
method of predicting protein-protein interactions is
not a genome level analysis and there could be other
binding partners for SEMA5A. Interestingly, along
with our prediction, Artigiani et al identified Plexin
B3 as a functional receptor for SEMA5A using trans-
fection experiments in Cos-7 cells (29 ). Nevertheless,
to our knowledge, our report is the first one to show
the interaction in the normal physiology of any type
of cells and in cancer cell lines.
The present study is a small scale prediction of
protein-protein interactions involving proteins shar-
ing similar ligand binding regions. The ligand bind-
ing regions of interacting proteins can be identified
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by computational prediction. However, we previously
used in vivo phage-display peptide library screening
to identify natural ligand binding regions (1 ). Fur-
thermore, in the same study we identified seven pu-
tative proteins sharing ligand binding regions with
SEMA5A using bioinformatics strategies. In the
present study, we have tried to identify the binding
partner for SEMA5A within the seven putative pro-
teins. Root-Bernstein and Dillon have demonstrated
that glucagon and glucagon receptor have peptide
complementarity in their ligand binding regions (21 ),
as well as many other proteins and their receptors. In
this study, we have observed similar protein comple-
mentarity in SEMA5A and putative proteins screened
from phage-display peptide library. Therefore, we
chose these proteins for further analysis as putative
SEMA5A binding proteins.
The verification of a SEMA5A binding partner in-
volved many analytical challenges. Careful consid-
eration and trustworthiness of the partners selected
were done to avoid the identification of false posi-
tives. Furthermore, we collected well-known functions
of SEMA5A and modeled other proteins to those func-
tions using the association rule. This increases the
likelihood of finding SEMA5A interacting partners
and reducing false positives. Previously, the functions
of proteins using the GO database have been used
to predict protein interactions (16 ). In the present
study, we have modeled a combination of GO func-
tional terms with the association rule to predict the
binding partners of SEMA5A. This analysis helped to
narrow down Plexin B3 and NRP2 as the most pos-
sible interacting partners of SEMA5A. In addition,
small scale text mining using cosine similarity demon-
strated the co-occurrence of Plexin B3 and NRP2 in
the literature. The co-occurrence of proteins in the
literature is an indication of functional relevance be-
tween proteins (16 , 33 ). Cosine similarity may not
give the right magnitude of distance between two
proteins that have been compensated by hierarchical
clustering of proteins using the association rule cal-
culation. However, many proteins of unknown func-
tion with few citations in the literature were chosen.
Consequently, cosine similarity for those proteins was
not considered as they were not significantly clustered
near SEMA5A. Furthermore, we did not consider in-
teractions within Semaphorin family of proteins for
simplicity. Therefore, we removed SEMA3C from the
list of SEMA5A interacting partners tested.
Molecular evidence indicates that the interaction
between proteins takes place through 4–7 amino acids
(1 ) at the ligand binding regions, and these ligand
binding regions of interacting proteins display inverse
hydropathic profiles leading to hydropathic comple-
mentarity (27 , 28 ). Furthermore, molecular recogni-
tion theory states that amino acids from complemen-
tary strands of DNA will have hydropathic comple-
mentarity and can bind to each other (27 , 28 , 34 ).
More accumulating evidence indicates that this the-
ory has been applied to design biologically active syn-
thetic analogs of receptor binding sites and to map
epitopes for antibodies (28 , 34–36 ). Previously, hy-
dropathic complementarity has not been applied to
identify protein-proteins interactions. In this report,
Plexin B3 and NRP2 were demonstrated to have hy-
dropathic complementarity with SEMA5A at the pu-
tative ligand binding region, suggesting their inter-
action. To our knowledge, for the first time we have
used hydropathic complementarity to verify the inter-
actions between putative binding partners.
Proteins sharing structural similarity and ligand
binding regions are already known to interact with
each other (21 ). We have already identified the struc-
ture of the sema domain of SEMA5A (1 ). Here we
have predicted the structure of the sema domain of
Plexin B3 by homology prediction method using the
structure of Met receptor as a template and showed
the similarity of Plexin B3 to SEMA5A. This is an-
other clue that these proteins may interact with each
other. These steps further suggest that Plexin B3
could be the binding partner for SEMA5A.
Evolutionarily interacting proteins are found to
be co-expressed in the same tissues and previously,
this co-expression was used to identify protein-protein
interactions (16 , 37–39 ). In the present study, we
verified the interaction of the identified proteins
by examining their co-expression in the same tis-
sues using Unigene expression and GNF microar-
ray expression databases as well as RT-PCR analy-
sis. Expression was further confirmed by performing
RT-PCR analysis using pancreatic cancer cell lines.
We observed expression of Plexin B3 and NRP2 in
SEMA5A-expressing and aggressive pancreatic can-
cer cell lines, indicating the co-expression of these pro-
teins. Meanwhile, SEMA5A and Plexin B3 co-evolved
together. Previously, interacting proteins were re-
ported to co-evolve (16 , 20 ). We showed that Plexin
B3 is closely related to SEMA5A phylogenetically.
Among the set of proteins analyzed, Plexin B3
is a promising candidate as a binding partner for
SEMA5A. We have confirmed our prediction using
immunoprecipitation experiments in rat tissues. In-
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dependently, our prediction was also confirmed by a
different group (29 ). By predicting the interacting
partners for SEMA5A, we are not only predicting the
functional receptor for SEMA5A, but also applying a
new approach to predict protein-protein interactions
through combinations of many different concepts. We
are aware that ligand binding regions of most pro-
teins are not known. However, it will be significant
to develop this analysis for genome-wide prediction of
protein binding partners by developing a database of
ligand binding sites of proteins identified either us-
ing phage-display peptide library or structure deter-
mination methods. We believe this is a confirmation
for the interaction of SEMA5A with Plexin B3, and
we predict that interaction is critical for cellular re-
sponses associated with pancreatic cancer progression
and metastasis.
Materials and Methods
Peptide complementarity
Proteins containing a sema domain are already known
to self-aggregate (or undergo homophilic interac-
tions) (40 , 41 ). SEMA5A may self-aggregate due
to the presence of a sema domain (unpublished
data). Therefore, the putative proteins that share
the binding signature NAFTPDY with SEMA5A were
grouped together based on RBD theories that peptide
receptors will contain ligand-like sequences within the
binding (extracellular) region, if the peptide is self-
complementary (21 ).
Hydropathic complementarity
Kyte and Doolittle hydropathic profile for proteins
was generated using ProtScale (42 , 43 ). The values
were plotted using Microsoft ExcelTM. The comple-
mentary regions on the graph were shaded in dark
solid lines (Figure 2).
Patterns of protein functions
To identify proteins that perform the same function,
biological processes, molecular functions and cyto-
plasmic components (in general, called terms) associ-
ated with SEMA5A were listed from the GO database
(44 ). Functional association of proteins was done us-
ing the frequency and confidence of co-occurrence of
each protein with SEMA5A. Let P = (p1, p2, . . . , pn)
be a set of proteins and F = (f1, f2, . . . , fm) be the
set of functional terms such that each protein may
or may not perform the function. Hence, Fi ⊆ P .
Depending on the presence (or absence) of Fi for P ,
a value of 1 (or 0) was assigned. The proteins were
later clustered using a hierarchical clustering method
with the Genesis software (45 ). Later, the fraction of
proteins containing the functional terms with pattern
X was calculated as Frac(X) = X/N , where X is
the number of Fi qualified as 1 for a protein and N
is the number of functional terms. The frequency of
co-occurrence of all the functional terms for proteins
with patterns X and Y for two different proteins was
calculated as Freq(X U Y ). The assumption is that
for two proteins to have the same function, the pres-
ence of pattern X for one protein implies the pres-
ence of pattern Y for the second protein with same
functional terms, Fi. Therefore, the confidence of the
functional association for two proteins was calculated
as Conf(X) = [Freq(X U Y )/Frac(X)]×100% (26 ).
Those associations greater than an arbitrary minimal
confidence of 75% were considered valid.
Analysis of biological literature for
functional relationship
To find the functional relationship between two pro-
teins, the co-occurrence of the proteins in the biologi-
cal literature was analyzed. Two bibliographic search
databases, Google Scholar and PubMed were queried.
The number of entries under each search is listed in
Table 2, and cosine similarity based distance metric
was used to find the relationship. Cosine similarity is
the measure of the cosine of the angle between two
vectors. The value is 1 when the two vectors are
identical and is 0 when the vectors are completely
orthogonal. The protein that has maximum cosine
similarity to the given protein is the one that is most
similar to it. Given two protein vectors X and Y,
the cosine co-efficient is: Sim(X,Y ) = X · Y/|X||Y |
(46 ). The cosine co-efficient measured the similarity
between protein vectors.
Co-expression of genes and protein in-
teraction
To find the co-expression of genes, Gene Expres-
sion Atlas (http://expression.gnf.org) text query was
used. The result for each gene was compared manu-
ally with that of the other genes. Furthermore, the
number of expressed sequence tags per million tags for
each gene in different organs was listed from Unigene
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Table 2 The number of entries for each bibliographic search using Google Scholar and PubMed*
Search key word Google scholar PubMed
Semaphorin + plexin + neuropilin 983 77
Semaphorin + plexin 1,930 202
Plexin + neuropilin 1,080 85
Semaphorin + neuropilin 2,710 305
Semaphorin 7,900 948
Neuropilin 7,000 698
Plexin 2,860 259
*Searched on December 31, 2007.
expression database (http://www.ncbi.nlm.nih.gov/
sites/entrez?db=unigene). The values were plotted in
a graph and compared with that of the other genes.
The co-expression of SEMA5A, Plexin B3 and NRP2
in pancreatic cancer was examined by RT-PCR using
respective primers. Total cellular RNA was isolated
from nine pancreatic cancer cell lines of different ori-
gin using Trizol reagent (Invitrogen, Carlsbad, CA,
USA) (47 ) and RT-PCR was performed as described
(48 ). First-strand cDNA was synthesized using to-
tal RNA (2 μg), oligo dT18 primer and superscript
II RT (Invitrogen); 2 μL of first-strand cDNA (1:10
dilutions) was amplified using PCR primer sets and a
thermal cycler (MJ Research, Waltham, MA, USA).
PCR fragments were separated on a 2% agarose gel
containing ethidium bromide (0.25 μg/mL), visual-
ized and analyzed using the Alpha Imager gel docu-
mentation system (Alpha Innotech, San Leandro, CA,
USA).
Domain-domain interactions
To elucidate the presence of similar domains in
SEMA5A and candidate proteins, SEMA5A was used
as a query for PSI-BLAST (49 ) with default param-
eters and the complete non-redundant database of
Homo sapiens. Furthermore, a BLAST-conserved do-
main search was performed for all three proteins with
default parameters and conserved domain database
(CDD) version 2.05 (50 , 51 ).
Protein modeling
Modeling of Plexin B3 was performed using the
web-based homology modeling server CPHmodels 2.0
(52 ) and further analysis was performed using Swiss-
PdbViewer as described earlier (1 , 53 ).
Co-immunoprecipitaion of SEMA5A
and Plexin B3
Normal brain, lung and liver tissues were lysed in a
buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM
NaCl, 1% Triton X-100 and protease inhibitors cock-
tail (Pierce, Rockford, IL, USA). For immunoprecipi-
taion, tissue lysates were incubated for 2 h with anti-
PlexinB3 antibody (pAbB3-A, generous gift from Dr.
Ulrich Finckh, Hamburg University, Germany) or IgG
control antibodies (1 μg/mL) followed by overnight
incubation with Protein A/G agarose (GE Health-
care, Piscataway, NJ, USA). Immune complexes were
washed three times with 1% Triton X-100 contain-
ing PBS (PBS-T), resolved on 8% SDS-PAGE and
immunoblotted with indicated antibodies. Following
protein electrotransfer, nylon membranes (Millepore,
Billerica, MA, USA) were probed with anti-SEMA5A
antibody. The blots were developed using an ECL
plus enhanced chemiluminescence kit (GE Helthcare).
Phylogenetic profile and protein inter-
actions
The sequences of members belonging to the
Semaphorin and Plexin families were selected from
NCBI Entrez and aligned using Clustal W (54 )
(http://workbench.sdsc.edu). A distance matrix was
generated using ProtDist in Phylip program (55 , 56 )
with Felsenstein’s categories, bootstrap options and
all other default parameters for the Clustal W align-
ment file (http://bioweb.pasteur.fr/seqanal/phylo-
geny/phylip-uk.html). Furthermore, the neighbor-
joining tree was generated using the Phylip neighbor
program with the bootstrap options for the distance
matrix obtained from ProtDist. Finally, Phyloden-
dron software (D.G. Gilbert version 0.8d) was used to
generate trees (http://www.es.embnet.org/Doc/phy-
lodendron/).
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